Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 91 - 100 of 101

Selected Filters:
14 March 2019

Addressing Gender to Ensure Effective PrEP Introduction

As new HIV prevention methods are rolled out, women, girls, men who have sex with men (MSM) and transgender people will face barriers to product access and use that stem from cultural norms, lack of power in relationships and society and limited access to resources. Gender analyses conducted in Kenya, South Africa and Zimbabwe identified…

Community/Advocacy, Demand Creation/Marketing

Document
1 February 2019

Implementation Plan for HIV Pre-Exposure Prophylaxis in Zimbabwe 2018-2020

Government of Zimbabwe's plan for the sustainable implementation of PrEP from 2018-2020. Published by the Ministry of Health & Child Care.

Normative Guidance/Policies

Document
28 January 2019

Dapivirine Ring Introduction Framework

The ring introduction framework highlights anticipated strengths, challenges, and key questions regarding introduction of the dapivirine ring in sub-Saharan Africa. It can be used by policymakers, implementers, and others planning for introduction of the dapivirine ring and other biomedical HIV prevention methods. The framework is based on several inputs including secondary research, interviews with key…

Demand Creation/Marketing, Financing & Costing, Monitoring & Evaluation, Research, Supply Chain Management

Document
17 December 2018

OPTIONS Plan 4 PrEP Toolkit: Rollout Scenarios

Step 3 in a six-part tookit use these scenarios and templates to explore oral PrEP rollout in different counties/districts or to different populations. This simple analysis, based on existing data, can provide quick cost and impact comparisons to guide decision-making.

Community/Advocacy, Demand Creation/Marketing

Document
17 December 2018

OPTIONS Plan 4 PrEP Toolkit: Situation Analysis Overview

Step 1 in a six-part toolkit to assist implementers rolling out oral PrEP. Use this as a guide for developing a situation analysis-a process that identifies stakeholders, existing assets, current gaps and key questions for next steps in the planning process.

Community/Advocacy, Demand Creation/Marketing

Document
13 December 2018

OPTIONS Consortium Overview

A two page overview of the OPTIONS consortium. This document describes its mission and objectives, membership and funding structure.

Service Delivery

External Link
1 November 2018

I-Tech Screening Tool

This very short screening tool was used by i-TECH Zimbabwe in its program offering PrEP to AGYW in Mazowe district. Ideal for rapid assessments in the field.

Research, Service Delivery

Document
1 August 2017

Assessment of Opportunities to Deliver Oral PrEP for Women Through Private Sector Health Care: Zimbabwe research findings

The objective of this research is to support planning by the Zimbabwean government, international donors and implementing agencies by providing an overview of the opportunities and considerations for delivering oral PrEP to women through the private sector. This analysis is focused on the delivery of oral PrEP and does not include other areas of potential…

Financing & Costing, Research, Monitoring & Evaluation

Document
21 October 2016

OPTIONS Review and Documentation of M&E Indicators for Oral PrEP

A summary of current monitoring and evaluation of demonstration projects that are delivering Oral PrEP. This overview includes a list of WHO recommended indicators which are also required for reporting under PEPFAR/OGAC.

Monitoring & Evaluation

Document
6 March 2016

MTN-003B

Archived from the MTN website before it was taken down. Primary Objective Compare changes in Bone Mineral Density (BMD) after one year among VOICE participants receiving oral tenofovir disoproxil fumarate (tenofovir or TDF) and emtricitabine (FTC)/TDF (Truvada) compared with oral placebo Study Summary The BMD Substudy was an observational substudy of VOICE designed to assess…

Research